India gearing up poll machinery to give 600 mn Covid vaccine jabs: Report
Serum Institute of India, the world's largest vaccine maker, is already mass producing and stockpiling AstraZeneca's Covishield shot12-12-2020
12-12-2020
COVID-19 vaccine: 3 out of 24,000 participants react adversely to Oxford-AstraZeneca candidate
AstraZeneca is currently seeking regulatory approval in many countries across the world. The company hopes that it will get the approval of MHRA, UK's regulator, within the next few weeks09-12-2020
Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine
The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose05-12-2020
Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine
The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.03-12-2020
AstraZeneca data, NovaVax delay spur Moderna Covid vaccine demand, says CEO
He also said that the higher efficacy rate "was in people younger than 55 years old."02-12-2020
AstraZeneca partner sticks with 2 full dose regimen in India Covid trials
The British drugmaker has said its COVID-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose01-12-2020
ICMR, DCGI probe alleged reaction to SII-AstraZeneca vaccine shot, trial continues
A 40-year-old man said that he had suffered serious "neurological and psychological" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII)30-11-2020
Adverse vaccine reaction: It's for sponsor, DSMB, and regulator to halt a trial'
Last week news emerged that a participant in the AstraZeneca-Oxford Covid vaccine trials in Chennai fell seriously ill. The information about this ad29-11-2020
COVID-19 vaccine: Serum Institute to apply for emergency use of vaccine in next 2 weeks
Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a 'very good' option28-11-2020
India Coronavirus Dispatch: What does '90% efficacy' for a vaccine mean?
Students aspiring to study abroad may face tougher competition in 2021, AstraZeneca's manufacturing error casts doubt over its potential, and other news relevant to India's fight against the pandemic28-11-2020